Post-surgical circulating tumor DNA monitoring is easier than pre-clinical detection because after surgery you know exactly how the patient's specific cancer differs from normal cells, making it simpler to look for residual disease than to prospectively detect unknown early cancers.
factualpending
Speaker
Unknown Speaker (Oncologist)Evidence Quote
“now that that's a much easier problem I mean I actually talked with Max Dean about that problem and he's one of the Pioneers in that field”
Created: 8/11/2026, 1:43:50 AM
Your notes
Loading notes...